kabutan

Genky DrugStares, First Half Ordinary Profit Increases by 24%, Oct-Dec Ordinary Profit Increases by 19%

Tue Jan 27, 2026 3:30 pm JST Earnings

9267 Genky DrugStores Co.,Ltd. 【J-GAAP】

Earnings Report

Genky DrugStores Co.,Ltd. <9267> [TSE Prime] announced its financial results after the market closed on January 27th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending June 2026 (July to December) increased 23.7% from the same period last year, reaching 5.84 billion yen. Progress toward the full-year plan of 11.2 billion yen was 52.2%, almost the same as the five-year average of 49.9%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to June period (second half) is expected to grow 3.5% from the same period last year, reaching 5.35 billion yen.

In the most recent three-month period, from October to December (2Q), the consolidated ordinary profit grew 19.1% from the same period last year, reaching 2.88 billion yen. The operating profit margin improved from 4.8% in the same period last year to 5.3%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jul - Dec, 2023 91,967 4,387 4,495 3,087 101.7 48.5 Jan 29, 2024 J-GAAP
Jul - Dec, 2024 98,758 4,596 4,722 3,268 107.6 47.7 Jan 27, 2025 J-GAAP
Jul - Dec, 2025 109,261 5,717 5,843 4,020 132.1 52.2 Jan 27, 2026 J-GAAP
YoY +10.6% +24.4% +23.7% +23.0% +22.8%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2025 Guidance 109,261 5,717 5,843 4,020 131.9 6.50 Jan 22, 2026 J-GAAP
Jul - Dec, 2025 Results 109,261 5,717 5,843 4,020 132.1 6.50 Jan 27, 2026 J-GAAP
Revision Rate 0.0% 0.0% 0.0% 0.0% +0.2%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 102,028 5,062 5,177 3,798 125.0 6.50 Jul 29, 2025 J-GAAP
Jan - Jun, 2026 Guidance 111,939 5,333 5,357 3,830 125.7 6.50 Jan 22, 2026 J-GAAP
YoY +9.7% +5.4% +3.5% +0.8% +0.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jun, 2024 184,860 9,015 9,268 6,324 208.2 12.75 Jul 29, 2024 J-GAAP
Jun, 2025 200,786 9,658 9,899 7,066 232.5 13 Jul 29, 2025 J-GAAP
Jun, 2026 Guidance 221,200 11,050 11,200 7,850 257.6 13 Jan 22, 2026 J-GAAP
YoY +10.2% +14.4% +13.1% +11.1% +10.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 48,708 2,324 2,422 1,684 55.4 4.8 Jan 27, 2025 J-GAAP
Jan - Mar, 2025 48,625 2,243 2,324 1,605 52.8 4.6 Apr 28, 2025 J-GAAP
Apr - Jun, 2025 53,403 2,819 2,853 2,193 72.2 5.3 Jul 29, 2025 J-GAAP
Jul - Sep, 2025 56,042 2,916 2,959 2,037 67.0 5.2 Oct 29, 2025 J-GAAP
Oct - Dec, 2025 53,219 2,801 2,884 1,983 65.2 5.3 Jan 27, 2026 J-GAAP
YoY +9.3% +20.5% +19.1% +17.8% +17.6%

Related Articles